Putting an Aussie lens on Veeva’s global omnichannel report

The recent Veeva Pulse Field Trends Report 2Q22[i] provided valuable insight into when, where and how field teams and healthcare professionals interact with the pharmaceutical industry representatives. However, the global report didn’t’ offer any Australia-specific findings. To fill this gap, Inside Healthcare conducted a similar study among AusDoc’s extensive GP database to provide deeper insights

Read more

Discover better with the new AusDoc community platform

AusDoc has become a whole lot better.   We are evolving into a community platform, allowing doctors to connect with their colleagues across the medical profession as well as keeping them informed with the latest news, opinion, clinical updates and education.  Given the ever-growing complexity of medicine, a community where doctors can discuss and debate the

Read more

How can pharma companies fill the gap in digital delivery?

Global report shows excitement about the potential of digital but a lack of confidence about delivery Pharma companies need to invest in the digital customer experience to add value now and in the future, according to a report by digital customer experience agency Graphite in partnership with Reuters Events. The global report titled the Contradiction Conundrum is

Read more

How to cover twice as many GPs without increasing your budget

A hybrid model that combines reps with digital solutions is a win-win for pharmaceutical companies and GPs. With face-to-face rep engagement returning to pre-COVID levels, pharmaceutical companies have an opportunity to use digital lessons learned during the pandemic to significantly increase the reach and frequency of their GP interactions without increasing their budget. The solution

Read more

Developing new communication strategies for the digital native doctor

About one in three Australian GPs is a digital native,1 which has fundamental implications for go-to-market strategies and a critical impact on how pharmaceutical companies promote the quality use of their medicines. Digital natives were born after 1980 and raised in an environment in which they were surrounded by technology (Palfrey and Gasser, 2013, Prensky, 2001).

Read more

Why engaging with GPs outside of working hours is crucial for pharma

Australian prescribers have tasted digital convenience and are unlikely to return to their pre-pandemic levels of face-to-face engagement with pharmaceutical representatives. That’s according to an in-depth report published by ADG in 2021 and a follow-up pulse survey among Australian Doctor readers conducted in January 2022[i]. The report titled How a GP initiated engagement model could

Read more

How life sciences organisations can help medical students shift from science to clinical practice

Being a member of the academic elite doesn’t necessarily make a good doctor, an AusDoc survey has revealed. From an experienced doctor’s perspective, high-achieving academics can face problems in practice. “Almost only the academic elite enter the system. This doesn’t necessarily make the best doctors…they are not used to failure and uncertainty and the hospital,

Read more

An expert’s roadmap to post-COVID and what it means for Pharma

COVID-19 modelling expert explains why it’s going to be trickier than many people think to vaccinate ourselves out of Delta Even as vaccination rates rise across Australia, it is unlikely that risk-averse medical practices will be allowing pharmaceutical reps to engage in face-to-face visits any time soon. So how can new digital GTM channels help to close this gap?  The only certainty

Read more